Flagship Pioneering and Samsung Announce Collaboration to Advance Groundbreaking Technologies in Translational Science and Medicine
CAMBRIDGE, Mass. and SEOUL, South Korea, Jan. 8, 2024 /PRNewswire/ — Flagship Pioneering, the bioplatform innovation company, and Samsung today announced a collaboration aimed at fostering cutting-edge biopharmaceutical innovation poised to transform the world of healthcare through groundbreaking advancements in translational science and medicine.
Related news for (SANA)
- Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
- 24/7 Market News Snapshot 23 June, 2025 – Sana Biotechnology, Inc. Common Stock (NASDAQ:SANA)
- Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions
- Sana Biotechnology to Present at June 2025 Investor Conferences
- Breaking News: MoBot’s Latest Update as of 05/20/25 03:00 PM